학술논문
1403-A PTPN2/N1 inhibitor ABBV-CLS-484 unleashes potent anti-tumor immunity
Document Type
article
Author
Wei Qiu; Qi Sun; Yi Yang; Chirag Patel; Meng Sun; Yue Liu; Kyle Halliwill; Sarah Kim; Rebecca Mathew; Jennifer M Frost; Jennifer A Roth; Domenick Kennedy; Robert T Manguso; Kathleen B Yates; Hakimeh Ebrahimi-Nik; Christina K Baumgartner; Arvin Iracheta-Vellve; Keith M Hamel; Kira Olander; Thomas GR Davis; Kathleen A McGuire; Geoff T Halvorsen; Omar I Avila; Ashwin V Kammula; Audrey J Muscato; Prasanthi Geda; Kelly Klinge; Zhaoming Xiong; Ryan Duggan; Liang Mu; Mitchell D Yeary; James C Patti; Tyler M Balon; Carey Backus; Angeline Chen; Kenton Longenecker; Joseph Klahn; Cara Hrusch; Navasona Krishnan; Charles W Hutchins; Jacqueline Aguado; Marinka Bulic; Payal Tiwari; Kayla J Colvin; Cun Lan Chuong; Ian C Kohnle; Matthew G Rees; Andrew Boghossian; Melissa Ronan; Meng-Ju Wu; Debattama R Sen; Gabriel K Griffin; Nabeel El-Bardeesy; Patricia Trusk; Joshua H Decker; Stacey Fossey; Marcia N Paddock; Elliot P Farney; Clay Beauregard; Philip R Kym
Source
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Subject
Language
English
ISSN
2051-1426